α-adrenergic receptor , auch: α adrenic receptor

Some species other than humans express a fourth α-adrenergic receptor as well.

Note that only the α-adrenergic receptors in active muscle will be blocked.

It does not appear to have any significant affinity for the D or α-adrenergic receptors.

It has several general functions in common with the α-adrenergic receptor, but also has specific effects of its own.

Influence of phospholipase A2 on human blood platelet α-adrenergic receptor function.

It is an α-adrenergic receptor agonist with some β effect.

Carvedilol blocks this binding to the α-adrenergic receptors too, which also lowers blood pressure.

Tamsulosin is relatively selective for α-adrenergic receptors, which are mainly present in the prostate.

As a result, it also acts as an α-adrenergic receptor antagonist to an extent.

Normally, α-adrenergic receptors predominates in smooth muscle of resistance vessels.

It is the only selective full agonist for the α-adrenergic receptors known to date and has been used to study their function in scientific research.

It is broadly classified as a centrally acting α-adrenergic receptor antagonist.

Additionally, most also act as α-adrenergic receptor antagonists.

These agents also commonly have action at α-adrenergic receptors and/or 5-HT receptors.

The vasoconstriction that pseudoephedrine produces is believed to be principally an α-adrenergic receptor response.

Like clonidine, it is an agonist of α-adrenergic receptors in certain parts of the brain.

It acts as an α-adrenergic receptor antagonist similarly to other imidazoles like idazoxan.

Various heterocyclic antidepressants and antipsychotics are α-adrenergic receptor antagonists as well.

For example, ajmalicine is a selective antagonist of α-adrenergic receptors and therefore has antihypertensive action.

Trazodone has been associated with the occurrence of priapism, likely due to its antagonism at α-adrenergic receptors.

Rauwolscine acts predominantly as a α-adrenergic receptor antagonist.

Efaroxan is an α-adrenergic receptor antagonist.

Monatepil is a calcium channel blocker and α-adrenergic receptor antagonist used as an antihypertensive.

It mainly affects dopamine D, serotonin 5-HT and α-adrenergic receptors.

Tolazoline is a non-selective competitive α-adrenergic receptor antagonist.